ClinicalTrials.govpublic full text
Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease
crohn's disease, certolizumab pegol, cdp870, cimzia, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 861407
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.